Effectiveness of infliximab after adalimumab failure in Crohn's disease

doi:10.3748/wjg.v18.i37.5219

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 37

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2254)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-2) series.

Item

Count

PDF

345

HTML

1745

Tables (1-2)

164

Sum=2254

Oct 7, 2012 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Oct 7, 2012; 18(37): 5219-5224
Published online Oct 7, 2012. doi: 10.3748/wjg.v18.i37.5219

Effectiveness of infliximab after adalimumab failure in Crohn's disease

María Chaparro, Montserrat Andreu, Manuel Barreiro-de Acosta, Esther García-Planella, Elena Ricart, Eugeni Domènech, María Esteve, Olga Merino, Pilar Nos, Mireia Peñalva, Javier P Gisbert

María Chaparro, Javier P Gisbert, Department of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Princesa (IP) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), 28006 Madrid, Spain

María Chaparro, Americio 17, portal E 2ºC, 28021 Madrid

Montserrat Andreu, Department of Gastroenterology, Hospital del Mar, 08003 Barcelona, Spain

Manuel Barreiro-de Acosta, Department of Gastroenterology, Hospital Clínico Universitario de Santiago, 15706 Santiago de Compostela, Spain

Esther García-Planella, Department of Gastroenterology, Hospital Santa Creu i Sant Pau, 08025 Barcelona, Spain

Elena Ricart, Department of Gastroenterology, Hospital Clínic, Barcelona, and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, 08916 Badalona, Spain

Eugeni Domènech, Department of Gastroenterology, Hospital Germans Trias i Pujol and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), 08916 Badalona, Spain

María Esteve, Department of Gastroenterology, Hospital Mutua de Terrassa, 08221 Barcelona, Spain

Olga Merino, Department of Gastroenterology, Hospital de Cruces, 48903 Bilbao, Spain

Pilar Nos, Department of Gastroenterology, Hospital Universitario La Fe and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), 46009 Valencia, Spain

Mireia Peñalva, Department of Gastroenterology, Hospital de Bellvitge, 08907 Barcelona, Spain

Author contributions: Chaparro M and Gisbert JP were involved in the study concept and design, the statistical analysis and writing of the manuscript; Chaparro M, Andreu M, Barreiro-de Acosta M, García-Planella E, Ricart E, Domènech E, Esteve M, Merino O, Nos P, Peñalva M and Gisbert JP were all involved in acquisition of data and reviewed the manuscript critically; and all the authors approved the final version of the manuscript.

Correspondence to: María Chaparro, MD, Americio 17, portal E 2ºC, 28021 Madrid, Spain. mariachs2005@gmail.com

Telephone: +34-91-3093911 Fax: +34-91-4022299

Received: March 22, 2011
Revised: September 17, 2011
Accepted: September 24, 2011
Published online: October 7, 2012

Core Tip